Travelers EVP Granted 7,407 Stock Options
The Travelers Companies, Inc. executive Rowland David Donnay, EVP & Co-Chief Investment Officer, reported a new stock option grant.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
The Travelers Companies, Inc. executive Rowland David Donnay, EVP & Co-Chief Investment Officer, reported a new stock option grant. On February 3, 2026, he was awarded 7,407 stock options with a conversion or exercise price of $288.23 per share.
These options relate to Travelers common stock, are held directly, and expire on February 3, 2036. Following this grant, Donnay beneficially owns 7,407 derivative securities in the form of these stock options.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Options (Right to Buy) | 7,407 | $0.00 | $0.00 |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Travelers (TRV) report for Rowland David Donnay?
How many stock options did the Travelers (TRV) executive receive in this Form 4?
What is the exercise price of the new Travelers (TRV) stock options?
When do the reported Travelers (TRV) stock options expire?
What position does the insider in this Travelers (TRV) Form 4 hold?
Are the Travelers (TRV) stock options held directly or indirectly by the insider?
AI-generated analysis. How Rhea-AI works. Not financial advice.